ALFA VETERINARY 0.9% SODIUM CHLORIDE- sodium chloride injection, solution injection, solution 
Laboratorios Alfa, S.R.L.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

DESCRIPTION

Veterinary 0.9% Sodium Chloride Injection, USP is a sterile, non-pyrogenic solution for fluid replenishment in single dose containers for intravenous administration. Discard unused portion. It contains no antimicrobial agents.

Table 1: Veterinary 0.9% Sodium Chloride Injection, USP
 Size (mL)

Compostion(mg/100 mL)

pHIonic Concentration (mEq/L)

 Sodium Chloride,

USP (NaCl)

 Osmolarity (mOsmol/L)
(Calculated)
SodiumChloride
 100900    308    4.5-7.0        154     154 
 250
 500
 1000

The Plastic container, a semi-rigid bottle, is made of a low density polyethylene which is a flexible and resistant material that provides an excellent compatibility with a maximum number of pharmaceuticals, reducing the risk of interactions. No venting is necessary during infusion.

OTHER SAFETY INFORMATION

CAUTION: Federal law (USA) restricts this drug to use by or on the order of a licensed veterinarian.

INDICATIONS AND USAGE

Veterinary 0.9% Sodium Chloride is indicated as a source of water and electrolytes.


Veterinary 0.9% Sodium Chloride injection, USP is also indicated for use as a priming solution in hemodialysis procedures.

CONTRAINDICATIONS

None known

WARNINGS

None known

PRECAUTIONS

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.

Caution must be exercised in the administration of veterinary 0.9% Sodium Chloride Injection, USP to patients receiving corticosteroids or corticotrophin.

Do not administer unless solution is clear, and seal is intact.

DOSAGE & ADMINISTRATION

As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient, as well as laboratory determinations.

Parenteral drug products should be inspected visually for particulate matter and discolorations prior to administration whenever solution and container permit.

All injections in plastic containers are intended for intravenous administration using sterile equipment.

Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used.

Consult with pharmacist, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced.

Do not store solutions containing additives. Discard unused portion.

Overdosage

In an event of over hydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See Warnings, Precautions and Adverse Reactions.

Packaging NDC 72483-203-10 1000 mL in Plastic Bottle; NDC 72483-203-05 500 mL in Plastic Bottle; NDC 72483-203-25 250 mL in Plastic Bottle; NDC 72483-203-01 100 mL in Plastic Bottle

NDC 72483-203-10 1000 mL in Plastic Bottle

NDC 72483-203-05 500 mL in Plastic Bottle

NDC 72483-203-25 250 mL in Plastic Bottle

NDC 72483-203-01 100 mL in Plastic Bottle

Storage

Store below 30​0C (86​0​F).

DIRECTIONS FOR USE PLASTIC CONTAINER

Preparation and administration (Use Aspetic Technique):

  1. Check for minute leaks by squeezing the container firmly. If leaks are found discard solutions as sterility may be impaired.
  2. Suspend container from eyelet support. 
  3. Remove Plastic protector from port area at bottom of container. 
  4. Hold bottle in vertical position and insert IV administration set in outlet port.

To add Medication: 

WARNING: Additives may be incompatible.

  1. Prepare medication site. 
  2. Using syringe with 19 to 22 gauge needle, puncture inlet port and inject. 
  3. Mix solution and medication thoroughly. Return container to in-use position and continue administration.

Caution

Federal law (USA) restricts this drug to use by or on the order of a licensed veterinarian.

OVERDOSAGE

In an event of over hydration or solute overload, re-evaluate the patient and institute appropriate corrective measures.

See Warnings, Precautions and Adverse Reactions.

STORAGE

Store below 30ºC (86ºF)

PRECAUTION FOR USE OF THE BOTTLE

This is a single dose container and does not contain preservatives.

Use the solution immediately after the bottle is opened, discard the remaining one.
Squeeze and inspect the bottle, discard if leaks are found or if the solution contains visible and solid particles.

Do not administer simultaneously with blood.
Do not use it unless solution is clear and seal is intact, the solution containing dextrose may be contraindicated in patients with a known allergy to corn or corn products.

DIRECTIONS FOR USE PLASTIC CONTAINER

Preparation and administration

  1. Check for minute leaks by squeezing the container firmly. If leaks are found, discard solution as sterility may be impaired.
  2. Suspend container from eyelet support.
  3. Remove Plastic protector from ports area at the bottom of container.
  4. Hold the bottle in vertical position and inset pyrogen free IV administration set in the outlet port. Use aseptic technique.

To Add Medication
WARNING:Additives may be incompatible.
To add medication before solution administration.

  1. Prepare medication site.
  2. Using syringe with 19 to 22 gauge needle, puncture inlet port and inject.
  3. Mix solution and medication thoroughly. Return container to in-use position and continue administration. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.

To add medication during solution administration

  1. Close clamp on the set.
  2. Prepare medication site.
  3. Using syringe with 19 to 22 gauge needle, puncture inlet port and inject.
  4. Remove container from IV pole and/or turn to an upright position.
  5. Mix solution and medication thoroughly.
  6. Return container to in use position and continue administration.

PACKAGE INSERT

For Animal Use Only

Veterinary 0.9% Sodium Chloride Injection (1)Veterinary 0.9% Sodium Chloride Injection (2)Veterinary 0.9% Sodium Chloride Injection (3)Veterinary 0.9% Sodium Chloride Injection (4)

PRINCIPAL DISPLAY PANEL

0.9% Sodium Chloride Injection, USP 

Veterinary Use

Sterile and NonProgenic Solution

Keep out of reach of Children.

For Animal Use Only.

Take Time - Observe label directions

Manufactured by:

Laboratorios Alfa, SRL

Santo Domingo

Domincan Republic

www.laboratoriosalfa.com

+1-809-544-0222

Veterinary 0.9% Sodium Chloride Injection (1000mL)Veterinary 0.9% Sodium Chloride Injection (500mL)Veterinary 0.9% Sodium Chloride Injection (250mL)Veterinary 0.9% Sodium Chloride Injection (100mL) description

ALFA VETERINARY 0.9% SODIUM CHLORIDE 
sodium chloride injection, solution injection, solution
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:72483-203
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE900 mg  in 100 mL
Inactive Ingredients
Ingredient NameStrength
Water (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72483-203-101000 mL in 1 BOTTLE, PLASTIC
2NDC:72483-203-05500 mL in 1 BOTTLE, PLASTIC
3NDC:72483-203-25250 mL in 1 BOTTLE, PLASTIC
4NDC:72483-203-01100 mL in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other12/04/2019
Labeler - Laboratorios Alfa, S.R.L. (815941244)

Revised: 12/2019
Document Id: b55411a8-23f5-419d-8da3-0614371d8d1b
Set id: f3756257-3007-41ac-80f1-c213a86c5a79
Version: 5
Effective Time: 20191209
 
Laboratorios Alfa, S.R.L.